Michael R. Hamblin

University of Johannesburg

Former affiliation

Harvard University

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Michael R. Hamblin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

7 Article

Probable positive effects of the photobiomodulation as an adjunctive treatment in COVID-19: A systematic review
Nejatifard, M., Asefi, S., Jamali, R., Hamblin, M. R. & Fekrazad, R., 1 Jan 2021, In: Cytokine. 137
Research output: Contribution to journal › Article › peer-review
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Lotfi, M., Hamblin, M. R. & Rezaei, N., 1 Sep 2020, In: Clinica Chimica Acta. 508
Research output: Contribution to journal › Article › peer-review
57 Scopus citations
Cytokines and COVID-19: friends or foes?
Rokni, M., Hamblin, M. R. & Rezaei, N., 2 Oct 2020, In: Human Vaccines and Immunotherapeutics. 16, 10
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Multivalent nanomedicines to treat COVID-19: A slow train coming
Tabish, T. A. & Hamblin, M. R., 1 Dec 2020, In: Nano Today. 35
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
Oroojalian, F., Haghbin, A., Baradaran, B., Hemmat, N., Shahbazi, M. A., Baghi, H. B., Mokhtarzadeh, A. & Hamblin, M. R., 15 Dec 2020, In: International Journal of Biological Macromolecules. 165
Research output: Contribution to journal › Article › peer-review
4 Scopus citations

Vielight Launches COVID-19 Clinical Trial With Home-Use Device
Michael R. Hamblin
14/10/20
1 item of Media coverage
Press/Media
Vielight Commences Recruitment for COVID-19 Clinical Trial in Ontario
Michael R. Hamblin
10/09/20
5 items of Media coverage
Press/Media
Vielight Launches COVID-19 Clinical Trial
Michael R. Hamblin
4/09/20
1 item of Media coverage
Press/Media
Vielight Launches COVID-19 Clinical Trial with Home-Use Device
Michael R. Hamblin
1/09/20
6 items of Media coverage
Press/Media
Two weeks, then gone? Doctors say no; Lingering and wide-ranging effects of COVID-19 are very real for people of all ages
A.M. Marty, Jason Kindrachuk, Aileen M. Marty & Michael R. Hamblin
15/07/20
1 item of Media coverage
Press/Media